IUPAC_name = 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
width = 159px
CAS_number = 51753-57-2
PubChem = 40113
C=15 | H=10| Br =1 | Cl=1 | N=2| O=1
molecular_weight = 349.609
elimination_half-life = 60 hours [http://www.ncbi.nlm.nih.gov/pubmed/7173273 Species differences in phenazepam kinetics and metabolism, National Center for Biotechnology Information, USA] ]
Phenazepam is a
benzodiazepinedrug, which was developed in Soviet Union and now produced in Russia and some CIS countries. Phenazepam is used in the treatment of neurological disorders such as epilepsy, alcohol withdrawaland insomnia. It can be used as a premedication before surgery as it augments the effects of anesthetics and reduces anxiety.
An average phenazepam dosage is 0.5 mg 2-3 times daily. The maximum daily dosage must not exceed 10 mg.
Side effects include
dizziness, loss of coordination and drowsiness, along with anterograde amnesiawhich can be quite pronounced at high doses. As with other benzodiazepines, in case of abrupt discontinuation following prolonged use, severe withdrawal symptoms may occur including restlessness, anxiety, insomniaand convulsions.
Phenazepam does not appear in the list of Controlled Substances in the Laws of either the USA or the UK, where in each country, benzodiazepines are generally Class C, Schedule IV substances.
In the United States the Controlled Substance Analogue Act applies only to substances in Schedule I and Schedule II. To this date there are no benzodiazepines in either of these schedules, and as such, all benzodiazepines not explicitly scheduled fall outside the analogue act.
According to the official investigation report, effects of phenazepam on pilot Pavel Gruzin may have contributed to errors that caused the crash of
Crossair Flight 498. [http://www.bfu.admin.ch/common/pdf/u1781_e Investigation Report of the Aircraft Accident Investigation Bureau on the accident to the Saab 340B aircraft, registration HB-AKK of Crossair Flight LX498 on 10 January 2000 near Nassenwil/ZH.] ]
Wikimedia Foundation. 2010.